01.03.2022 22:03:23
|
Rigel Pharmaceuticals Inc. Q4 loss increases in line with estimates
(RTTNews) - Rigel Pharmaceuticals Inc. (RIGL) reported Loss for its fourth quarter that increased from last year in line with the Street estimates.
The company's earnings totaled -$22.64 million, or -$0.13 per share. This compares with -$19.24 million, or -$0.11 per share, in last year's fourth quarter.
Analysts on average had expected the company to earn -$0.13 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 10.6% to $20.41 million from $18.45 million last year.
Rigel Pharmaceuticals Inc. earnings at a glance (GAAP) :
-Earnings (Q4): -$22.64 Mln. vs. -$19.24 Mln. last year. -EPS (Q4): -$0.13 vs. -$0.11 last year. -Analyst Estimate: -$0.13 -Revenue (Q4): $20.41 Mln vs. $18.45 Mln last year.
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Rigel Pharmaceuticals IncShsmehr Nachrichten
Keine Nachrichten verfügbar. |